LMR Partners’s Korro Bio KRRO Stock Holding History

LMR Partners’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-231	Closed	-$21K	–	1192
2022 Q3	$21K	Hold	231	–	–	﹤0.01%	1160
2022 Q2	$17K	Buy	+231	New	+$15.6K	﹤0.01%	1241
2021 Q2	–	Sell	-1,198	Closed	-$569K	–	1232
2021 Q1	$569K	Buy	+1,198	New	+$2.33M	0.01%	602

Other funds holding KRRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LMR Partners's KRRO Position: Q4 2022 in Review

LMR Partners sold out of Korro Bio (KRRO) in Q4 2022, closing a stake of 231 shares — an estimated $21K sold.

LMR Partners first reported a position in KRRO in Q1 2021 and held it in 3 quarters. The position peaked at $569K in Q1 2021. 49 funds tracked by Wall St. Rank hold KRRO as of Q4 2022.

LMR Partners reported no remaining Korro Bio position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 231 Korro Bio shares in Q4 2022, an estimated $21K.
LMR Partners first reported a position in Korro Bio in Q1 2021 and held it in 3 quarters.
LMR Partners's Korro Bio position peaked at $569K in Q1 2021.
49 funds tracked by Wall St. Rank held Korro Bio as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.